Aidoc AI

Enterprise licensing to health systems and radiology groups. No public pricing. FDA-cleared for multiple indications. Contact for pricing.

Butterfly iQ3 probe $2,999. Software subscription $399/year/user. Enterprise custom. FDA cleared.

Medical image and clinical data processed under HIPAA BAA and applicable healthcare privacy regulations. FDA-cleared for specific clinical indications — review clearance scope for each deployment.

Medical imaging data processed on Butterfly Network's HIPAA-compliant cloud platform. All data handling under applicable healthcare privacy regulations.

• ✓Broadest portfolio of FDA-cleared radiology AI algorithms — regulatory clearance required for clinical deployment
• ✓Worklist prioritisation for time-critical conditions (stroke, PE) has direct patient outcome impact
• ✓aiOS platform enables health systems to manage multiple AI algorithms through one integration
• ✓Published clinical evidence from real-world deployments validates outcomes claims

• ✓Revolutionary hardware democratises ultrasound access — $2,999 vs $40,000+ for traditional machines
• ✓AI probe guidance enables non-sonographer clinicians to obtain diagnostic images
• ✓Global health applications in resource-limited settings where traditional ultrasound is unavailable
• ✓FDA clearance provides regulatory legitimacy for clinical deployment

• ✕Enterprise health system sales cycles are long and require IT, clinical, and procurement alignment
• ✕FDA clearance is indication-specific — algorithms not cleared for a specific indication cannot be deployed clinically
• ✕Integration with existing PACS and RIS systems requires significant IT implementation effort

• ✕Probe + subscription model requires ongoing cost even for occasional users
• ✕AI interpretation accuracy varies by clinical indication — not all findings are equally reliably detected
• ✕Traditional ultrasound quality still surpasses handheld for many diagnostic applications requiring expert sonography